|
|
||||||||
Part 8: PD Peritonitis |
Center for Health and Biological Sciences,1 Pontifícia Universidade Católica do Paraná, Curitiba, and Department of Internal Medicine,2 University Hospital, Botucatu School of Medicine, UNESP, Sao Paulo, Brazil
Correspondence to: R. Pecoits–Filho, Centro de Ciências Biológicas e da Saúde, Rua Imaculada Conceição, 1155, Curitiba PR 80215 Brazil. r.pecoits{at}pucpr.br
Despite improvements in connectology, peritoneal dialysis
(PD)–associated peritonitis contributes significantly to morbidity and
modality failure in patients maintained on PD therapy. A broad spectrum of
organisms—gram-positive, gram-negative, fungal, anaerobic—are
involved in this complication. In addition, a significant percentage of
episodes involve polymicrobial and culture-negative infection. Technological
advances are being developed to minimize the incidence of access-related
complications such as peritonitis. Many traditional factors such as exit-site
infection and poor technique have been already identified. In the present
review, we discuss the geographic, patient selection, and clinical issues that
can affect peritonitis rates in different areas of the world and in different
centers in the same area.
KEY WORDS: Peritonitis; infection; risk factors; complications.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |